The clinical program for sonelokimab now includes patients with adolescent hidradenitis suppurativa (HS), palmoplantar pustulosis (PPP) and axial spondyloarthritis (axSpA), in addition to adult ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback